Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Glimepiride + metformin + vildagliptin) by Laboratorios Silanes for Type 2 Diabetes: Likelihood of Approval
(Glimepiride + metformin + vildagliptin) is under clinical development by Laboratorios Silanes and currently in Phase III for Type 2...